These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21094206)

  • 1. Genetics and genomics of childhood adrenocortical tumors.
    El Wakil A; Doghman M; Latre De Late P; Zambetti GP; Figueiredo BC; Lalli E
    Mol Cell Endocrinol; 2011 Apr; 336(1-2):169-73. PubMed ID: 21094206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
    Faria AM; Almeida MQ
    Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular pathogenesis of childhood adrenocortical tumors.
    Almeida MQ; Latronico AC
    Horm Metab Res; 2007 Jun; 39(6):461-6. PubMed ID: 17578765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the mTOR pathway in normal and tumoral adrenal cells.
    De Martino MC; van Koetsveld PM; Pivonello R; Hofland LJ
    Neuroendocrinology; 2010; 92 Suppl 1():28-34. PubMed ID: 20829615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation.
    Rosati R; Cerrato F; Doghman M; Pianovski MA; Parise GA; Custódio G; Zambetti GP; Ribeiro RC; Riccio A; Figueiredo BC; Lalli E
    Cancer Genet Cytogenet; 2008 Oct; 186(1):19-24. PubMed ID: 18786438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inheritance of R337H p53 gene mutation in children with sporadic adrenocortical tumor.
    Sandrini F; Villani DP; Tucci S; Moreira AC; de Castro M; Elias LL
    Horm Metab Res; 2005 Apr; 37(4):231-5. PubMed ID: 15952083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology, clinical characteristics, and management of adrenocortical tumors in children.
    Rodriguez-Galindo C; Figueiredo BC; Zambetti GP; Ribeiro RC
    Pediatr Blood Cancer; 2005 Sep; 45(3):265-73. PubMed ID: 15747338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes.
    Letouzé E; Rosati R; Komechen H; Doghman M; Marisa L; Flück C; de Krijger RR; van Noesel MM; Mas JC; Pianovski MA; Zambetti GP; Figueiredo BC; Lalli E
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1284-93. PubMed ID: 22539591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectives.
    Bertherat J; Groussin L; Bertagna X
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):632-41. PubMed ID: 17082810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.
    Fottner Ch; Hoeflich A; Wolf E; Weber MM
    Horm Metab Res; 2004 Jun; 36(6):397-405. PubMed ID: 15241731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations.
    Mastellaro MJ; Ribeiro RC; Oliveira-Filho AG; Seidinger AL; Cardinalli IA; Miranda ECM; Aguiar SS; Brandalise SR; Yunes JA; Barros-Filho AA
    J Pediatr (Rio J); 2018; 94(4):432-439. PubMed ID: 28864397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist].
    Tissier F
    Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors.
    Gicquel C; Raffin-Sanson ML; Gaston V; Bertagna X; Plouin PF; Schlumberger M; Louvel A; Luton JP; Le Bouc Y
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2559-65. PubMed ID: 9253334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
    Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
    Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of adrenocortical tumors in southern Brazil.
    Custódio G; Komechen H; Figueiredo FR; Fachin ND; Pianovski MA; Figueiredo BC
    Mol Cell Endocrinol; 2012 Mar; 351(1):44-51. PubMed ID: 22056871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
    Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
    Gicquel C; Bertagna X; Gaston V; Coste J; Louvel A; Baudin E; Bertherat J; Chapuis Y; Duclos JM; Schlumberger M; Plouin PF; Luton JP; Le Bouc Y
    Cancer Res; 2001 Sep; 61(18):6762-7. PubMed ID: 11559548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Involvement of the IGF system in the pathogenesis of adrenocortical tumors].
    Gicquel C; Boulle N; Logié A; Bourcigaux N; Gaston V; Le Bouc Y
    Ann Endocrinol (Paris); 2001 Apr; 62(2):189-92. PubMed ID: 11353893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental alkaline phosphatase in pediatric adrenocortical cancer.
    Boechat GA; Stinghen ST; Custódio G; Pianovski MA; Figueiredo FR; Jenkins J; Zambetti GP; Ribeiro RC; Figueiredo BC
    J Pediatr Hematol Oncol; 2011 May; 33(4):e149-53. PubMed ID: 21516013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.
    Shibata T; Saito S; Kokubu A; Suzuki T; Yamamoto M; Hirohashi S
    Cancer Res; 2010 Nov; 70(22):9095-105. PubMed ID: 21062981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.